Drugs.com - FDA MedWatch Alerts

Astellas Issues Recall of One Lot of Prograf 0.5 mg and One Lot of Astagraf XL 0.5 mg Because Bottles Shipped to U.S. May Contain Empty Capsules

Audience: Healthcare Provider, Pharmacy, Consumer NORTHBROOK, IL, Dec. 23, 2024 – Astellas Pharma US, Inc. (Head of US Commercial: Michael Petroutsas, "Astellas") is voluntarily recalling one lot of Prograf® 0.5mg (tacrolimus) and one lot...

Feb 9, 2025 - 21:44
 0
Astellas Issues Recall of One Lot of Prograf 0.5 mg and One Lot of Astagraf XL 0.5 mg Because Bottles Shipped to U.S. May Contain Empty Capsules
Audience: Healthcare Provider, Pharmacy, Consumer NORTHBROOK, IL, Dec. 23, 2024 – Astellas Pharma US, Inc. (Head of US Commercial: Michael Petroutsas, "Astellas") is voluntarily recalling one lot of Prograf® 0.5mg (tacrolimus) and one lot...
Read More

Tags:

Previous Article

FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Informatio...

Next Article

Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Soluti...

Related Posts

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling

Endo Expands Voluntary Recall of Clonazepam Orally Disi...

Feb 9, 2025  0

One Source Nutrition, Inc. Issues Voluntary Nationwide Recall of Vitality Capsules Due to Presence of Undeclared Sildenafil and Tadalafil

One Source Nutrition, Inc. Issues Voluntary Nationwide ...

Feb 23, 2025  0

FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy

FDA Requires Guillain-Barré Syndrome (GBS) Warning in t...

Feb 9, 2025  0